GlobalSpace Technologies adds another marquee Pharma Major - Macleods Pharma for its DocExa pro platform

GlobalSpace Technologies has continued its march ahead in the HealthTech domain as the company has added another marquee logo - Macleods Pharma for its DocExa pro platform. The alliance with Macleods Pharma is the second major alliance followed by its strategic tie-up with Cadila earlier. With two major Pharma names - Macleods Pharma and Cadila to its client list, DocExa is emerging to be one of the leading Virtual Consultation App, which is first of its kind Artificial Intelligence (AI) enabled. The app would enable Doctors to set up their own personalized virtual consultation clinic with zero exposure of patient database getting shared with other doctors. Equipped with AS2 advanced levels encryption, all the data's remain highly secured in the app. The app would enable patients to have option of securely uploading individual EMR - Electronic Medical Records. Doctors would be able to prescribe medicines with three different easy modes and charge consultation fees as per their discretion.

Macleods Pharma alliance is another major breakthrough as the pharma major would take the DocExa platform to the specialists Doctors mainly Cardiologist & Diabetologist. Thus, it places DocExa into the specialists category of consulting - more value addition. Thus, the company is making strong inroads into the Digital Healthcare Consulting domain - across the non-critical and even specialists' category. The entire integrated platform with Mediapp - is likely to substantially increase the wallet share for GlobalSpace towards the Healthcare spend. With a distinguished early mover advantage and superior platform, GlobalSpace is likely to garner larger pie of healthcare spends.

Commenting on the alliance with Macleods Pharma, Mr. Krishna Singh, Founder & CMD, 'We at GlobalSpace have added another feather in the cap as we have now entered into alliance with another marquee Pharma major - Macleods Pharma for our AI-based DocExa pro platform. This is the second major breakthrough with a Pharma company following our strategic alliance with Cadila. Macleods Pharma would help GlobalSpace in taking its platform to the specialists consulting space especially Cardiologist & Diabetologist. The alliance gives a substantial large platform for scaling our DocExa reach and garnering a substantial market share in the Digital Healthcare Space. GlobalSpace has emerged as a 360-degree Digital Healthcare service provider'.

Shares of Globalspace Technologies Ltd was last trading in BSE at Rs.60 as compared to the previous close of Rs. 65. The total number of shares traded during the day was 21269 in over 41 trades.

The stock hit an intraday high of Rs. 72 and intraday low of 60. The net turnover during the day was Rs. 1364063.

Source : Equity Bulls

Keywords